Esophageal acid suppression reveals hidden acid–symptom phenotypes in GERD :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Why some GERD patients feel more heartburn than others: New study provides answers!

GERD GERD
GERD GERD

What's new?

Patients with GERD exhibit distinct acid–symptom phenotypes following acid suppression, suggesting a potential role for phenotype-guided disease management.

The relationship between esophageal acid exposure and symptom severity in gastroesophageal reflux disease (GERD) is often complex, with high levels of reflux potentially obscuring individual patterns of symptom perception. Against this backdrop, researchers examined whether suppressing post-meal acid exposure using omeprazole (proton pump inhibitors; PPIs) or ranitidine plus antacid could differentiate patient-specific acid–symptom profiles. They conducted two complementary clinical investigations using standardized meal-provocation testing in patients with GERD.

  • In the 1st study, participants underwent assessment at baseline and again after eight days of omeprazole treatment.
  • The 2nd study utilized a randomized crossover design in which subjects received both placebo and a combination of ranitidine + antacid.

Following meal consumption, esophageal acid exposure and heartburn severity were systematically measured for 3 hours in the omeprazole cohort and 4.5 hours in the ranitidine-plus-antacid cohort. The data was subsequently analyzed using receiver operating characteristic methodology and phenotype-based stratification to characterize relationships between acid burden and symptom perception. Both omeprazole and ranitidine + antacid noticeably reduced post-meal esophageal acid exposure and heartburn severity, while revealing previously hidden differences in how patients experienced reflux symptoms.

Key findings included:

  • Both therapies delivered meaningful reductions in post-prandial acid burden and heartburn severity.
  • Untreated patients predominantly exhibited high reflux exposure with severe symptoms.
  • Acid suppression uncovered previously masked acid–symptom phenotypes.
  • Discordant response patterns were comparable between treatment groups.
  • Variations in concordant phenotypes highlighted distinct pharmacologic influences on symptom generation.

The findings suggest that symptom burden in GERD cannot always be explained solely by the degree of acid exposure. By diminishing esophageal acid levels, therapies such as omeprazole or ranitidine combined with antacid may reveal latent patient-specific patterns of reflux perception and symptom sensitivity. These phenotypes could help explain why some patients continue to experience symptoms despite adequate acid suppression, while others achieve substantial relief even when residual acid exposure persists.

Source:

Digestive Diseases and Sciences

Article:

Esophageal Acid Suppression Unmasks Latent Esophageal Acid-Symptom Phenotypes in GERD

Authors:

Jerry D Gardner et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: